U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry UNKNOWN
Molecular Formula C18H17ClN2O
Molecular Weight 312.793
Optical Activity ( + )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CLAZOLAM, (+)-

SMILES

CN1C2=C(C=C(Cl)C=C2)C3N(CCC4=CC=CC=C34)CC1=O

InChI

InChIKey=YAQKGZXXQNKEET-UHFFFAOYSA-N
InChI=1S/C18H17ClN2O/c1-20-16-7-6-13(19)10-15(16)18-14-5-3-2-4-12(14)8-9-21(18)11-17(20)22/h2-7,10,18H,8-9,11H2,1H3

HIDE SMILES / InChI

Molecular Formula C18H17ClN2O
Molecular Weight 312.793
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Clazolam (isoquinazepon) is a fuzed benzodiazepine drug developed by Sandoz in the 1960s. The drug is claimed to have anxiolytic properties, which are manifested in a reduction of cramping, antagonism of amphetamine, and by inhibition of spinal reflexes.

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 11:15:39 GMT 2023
Edited
by admin
on Sat Dec 16 11:15:39 GMT 2023
Record UNII
GYR9E8U0NH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CLAZOLAM, (+)-
Common Name English
ISOQUINO(2,1-D)(1,4)BENZODIAZEPIN-6(7H)-ONE, 2-CHLORO-5,9,10,14B-TETRAHYDRO-5-METHYL-, (+)-
Common Name English
Code System Code Type Description
PUBCHEM
24107
Created by admin on Sat Dec 16 11:15:39 GMT 2023 , Edited by admin on Sat Dec 16 11:15:39 GMT 2023
PRIMARY
CAS
10171-69-4
Created by admin on Sat Dec 16 11:15:39 GMT 2023 , Edited by admin on Sat Dec 16 11:15:39 GMT 2023
PRIMARY
EPA CompTox
DTXSID50274072
Created by admin on Sat Dec 16 11:15:39 GMT 2023 , Edited by admin on Sat Dec 16 11:15:39 GMT 2023
PRIMARY
FDA UNII
GYR9E8U0NH
Created by admin on Sat Dec 16 11:15:39 GMT 2023 , Edited by admin on Sat Dec 16 11:15:39 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT